ContractApril 11th, 2019
FiledApril 11th, 2019CLINICAL TRIAL AGREEMENT Protocol ID-054-304 SMLOUVA O KLINICKÉM HODNOCENÍ Protocol ID-054-304 This clinical study agreement on conducting a clinical study made in compliance with the provision of § 1746, paragraph 2, Act No. 89/2012 Coll., Civil Code, as amended and in compliance with Act No. 378/2007 Coll. on Pharmaceuticals, as amended (the “Agreement”) is entered into as of the date of last signature hereto (the “Effective Date”), and shall take effect on the day of its publication in the register of contracts, by and between Idorsia Pharmaceuticals Ltd, having as a place of business Hegenheimermattweg 91 CH – 4123 Allschwil, Switzerland (“Idorsia”), Faculty Hospital Hradec Králové, Sokolská 581, 500 05 Hradec Králové – Nový Hradec Králové, Czech Republic, represents by prof. MUDr. Vladimír Palička, CSc., dr. h. c., Director, VAT/Tax ID CZ00179906 (the “Institution”), and(the “Investigator”). Idorsia, Institution and Investigator referred to individually herein as a “Party” or coll